The "big three" insulin manufacturers, Eli Lilly, Novo Nordisk, and Sanofi, have all recently announced price reductions. Here are a few answers to your questions:
No, the price crisis isn't over.
No, healthcare isn't affordable now.
No, I'm not grateful to the manufacturers.